Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06163482 · ClinicalTrials.gov registry record · Early Phase 1
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
A Early Phase 1 study of Cystic Fibrosis, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT06163482 is a Early Phase 1 study of Cystic Fibrosis that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 61 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06163482, a Early Phase 1 study of Cystic Fibrosis, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.
Conditions Studied
Interventions
- OTHER Mixed meal
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2026-12-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06163482
The ClinicalTrials.gov registry entry for NCT06163482 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (66% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Mixed meal is the first listed.
NCT06163482 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06163482 about?
NCT06163482 is a clinical study titled "Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis". In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.
What is the current status of trial NCT06163482?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 61 participants. The study started on 2023-03-28. Estimated completion is 2026-12-30.
What conditions does trial NCT06163482 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT06163482?
The interventions under investigation include: Mixed meal (OTHER).
Who is sponsoring clinical trial NCT06163482?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06163482 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Regional Monitoring of CF Lung Disease
RECRUITING · Early Phase 1
-
Personalized Theratyping Trial
RECRUITING · Early Phase 1
-
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
ACTIVE NOT RECRUITING · Early Phase 1
-
19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis
COMPLETED · Early Phase 1
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.